|
V0180
|
(-)-Blebbistatin
|
856925-71-8 |
Blebbistatin is a potent, selective, reversible and cell-permeable small molecule inhibitor for non muscle myosin II ATPase with IC50 of around 2 μM in cell-free assays. |
|
V2325
|
BRITE-338733
|
503105-88-2 |
BRITE-338733 is a RecA ATPase inhibitor (antagonist) with IC50 of 4.7 µM. |
|
V0191
|
BTB06584
|
219793-45-0 |
BTB06584 (BTB-06584; BTB 06584) is a novel, potent and IF1-dependent inhibitor of the mitochondrial F1 Fo-ATPase, acting by selectively inhibiting mitochondrial F1 Fo-ATPase activity without compromising ATP synthesis and to limit ischaemia-induced injury caused by reversal of the mitochondrial F1 Fo-ATPsynthase. |
|
V8748
|
Bufalin
|
465-21-4 |
Bufalin is a novel and potent inhibitor of steroid receptor coactivator 3 (SRC-3) with anticancer,anti-inflammatory and antinociceptive activity. |
|
V17787
|
CDN-1163
|
892711-75-0 |
CDN-1163 is a small molecule activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). |
|
V2377
|
KM 91104
|
304481-60-5 |
KM91104 is a cell-penetrating/penetrable V-ATPase inhibitor that specifically targets the a3-b2 subunit of V-ATPase. |
|
V25685
|
ML367
|
381168-77-0 |
ML367 is a novel andpotent inhibitor of ATPase family AAA domain-containing protein 5 (ATAD5) stabilization, it acts as a probe molecule that has low micromolar inhibitory activity. |
|
V26869
|
Oleandrin
|
465-16-7 |
Oleandrin (PBI-05204) inhibits Na+, K+-ATPase activity with IC50 of 620 nM. |
|
V26870
|
Oleic acid
|
112-80-1 |
Oleic acid(also known as 9-cis-Octadecenoic acid; 9Z-Octadecenoic acid) is the most common and abundantmonounsaturatedfatty acid (FA), acting asaNa+/K+ATPaseactivator. |
|
V6322
|
Oxytetracycline
|
79-57-2 |
Oxytetracycline (Lenocycline; Oxyterracine; Oxyterracyne; Tarosin; Oxymykoin) is a naturally occurring tetracycline class of antibiotic extracted from the
actinomycete STREPTOMYCES rimosus with a broad-spectrum of antibacterial effects. |
|
V6079
|
Rhodamine 123 (RH-123; R-22420)
|
62669-70-9 |
Rhodamine dyes are membrane-permeable/penetrable cationic fluorescent probes that can specifically identify mitochondrial membrane potential, thereby attaching to mitochondria and producing bright fluorescence. |
|
V16014
|
Tegoprazan
|
942195-55-3 |
Tegoprazan, a novel and potent P-CAB (potassium-competitive acid blocker),is a next-generation therapeutics developed for the treatment of acid-related gastrointestinal diseases such as gastroesophageal reflux disease (GERD) and peptic ulcers, acting bycontroling gastric acid secretion and motility. |
|
V9143
|
Thapsigargin
|
67526-95-8 |
Thapsigargin is a novel and potent non-competitive inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) and an Endoplasmic Reticulum (ER) stress inducing agent. |